Phong Phu Pharmaceutical JSC (HNX:PPP)
Vietnam · Delayed Price · Currency is VND 20,000
-100 (-0.50%)
At close: Nov 3, 2026
HNX:PPP Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 167,823 | 139,740 | 137,548 | 152,172 | 150,575 | 133,289 |
Revenue Growth | 24.33% | 1.59% | -9.61% | 1.06% | 12.97% | 14.65% |
Gross Profit Gross Profit Growth | 68,466 | 49,329 | 46,404 | 49,156 | 51,290 | 45,237 |
Operating Income Operating Income Growth | 38,396 | 21,200 | 20,255 | 23,110 | 25,194 | 19,693 |
Net Income Net Income Growth | 35,744 | 16,571 | 15,548 | 18,138 | 20,611 | 16,893 |
Earnings Per Share EPS Growth | 4141.97 | 1883.11 | 1766.77 | 2061.13 | 2112.00 | 1725.00 |
EPS Growth | 133.10% | 6.59% | -14.28% | -2.41% | 22.43% | 73.37% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 67,934 | 49,624 | 39,984 | 32,044 | 26,301 | 18,118 |
Total Debt Total Debt Growth | 9,112 | 6,287 | - | - | - | 2,000 |
Net Cash (Debt) Net Cash Growth | 58,822 | 43,337 | 39,984 | 32,044 | 26,301 | 16,118 |
Net Cash Growth | 86.89% | 8.38% | 24.78% | 21.84% | 63.18% | - |
Net Cash Per Share Net Cash Per Share Growth | 6816.12 | 4924.64 | 4543.68 | 3641.42 | 2694.95 | 1645.87 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 35,800 | 16,796 | 17,336 | 22,050 | 20,936 | 19,279 |
Capital Expenditures CapEx Growth | -2,194 | -1,524 | -549.86 | -4,622 | -818.79 | -1,149 |
Free Cash Flow Free Cash Flow Growth | 33,606 | 15,272 | 16,787 | 17,428 | 20,117 | 18,129 |
Free Cash Flow Growth | 131.60% | -9.02% | -3.68% | -13.37% | 10.97% | 100.44% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.80% | 35.30% | 33.74% | 32.30% | 34.06% | 33.94% |
Operating Margin | 22.88% | 15.17% | 14.73% | 15.19% | 16.73% | 14.77% |
Pretax Margin | 28.07% | 16.60% | 15.86% | 16.16% | 17.14% | 14.59% |
Profit Margin | 21.30% | 11.86% | 11.30% | 11.92% | 13.69% | 12.67% |
FCF Margin | 20.03% | 10.93% | 12.20% | 11.45% | 13.36% | 13.60% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1500.000 | - | 1500.000 | 1200.000 | 1400.000 |
Dividend Per Share Growth | 0% | - | 25.00% | -14.29% | - |
Dividend Yield | 7.50% | - | 8.48% | 7.23% | 10.85% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.83 | 10.89 | 10.02 | 7.18 | 5.51 | 9.17 |
P/FCF Ratio | 5.24 | 11.81 | 9.28 | 7.47 | 5.64 | 8.54 |
PS Ratio | 1.05 | 1.29 | 1.13 | 0.86 | 0.75 | 1.16 |